| # | Drug | Count |
|---|---|---|
| 0 | ALENDRONATE SODIUM | 33 |
| 1 | METHOTREXATE SODIUM | 18 |
| 2 | METHOTREXATE | 16 |
| 3 | CISPLATIN | 12 |
| 4 | DOXORUBICIN | 12 |
| 5 | PREDNISONE | 11 |
| 6 | FUROSEMIDE | 10 |
| 7 | DENOSUMAB | 9 |
| 8 | OMEPRAZOLE MAGNESIUM | 9 |
| 9 | CALCIUM | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PENICILLAMINE | 3 | 0.0032 |
| 1 | PAMIDRONATE DISODIUM | 6 | 0.0018 |
| 2 | LAROTRECTINIB | 1 | 0.0011 |
| 3 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 3 | 0.0011 |
| 4 | ENTRECTINIB | 1 | 0.0006 |
| 5 | CYCLOBENZAPRINE HYDROCHLORIDE | 4 | 0.0004 |
| 6 | TRIPTORELIN PAMOATE | 1 | 0.0004 |
| 7 | LANREOTIDE ACETATE | 3 | 0.0004 |
| 8 | GOLD | 2 | 0.0003 |
| 9 | FAMOTITINE | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 18 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 16 |
| 2 | Platinum-based Drug [EPC] | 12 |
| 3 | Loop Diuretic [EPC] | 10 |
| 4 | Proton Pump Inhibitor [EPC] | 9 |
| 5 | RANK Ligand Inhibitor [EPC] | 9 |
| 6 | Benzodiazepine [EPC] | 8 |
| 7 | Calcium [EPC] | 8 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 7 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Calcitonin [EPC] | 1 | 0.0003 |
| 1 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |
| 2 | Barbiturate [EPC] | 1 | 0.0001 |
| 3 | Potassium-sparing Diuretic [EPC] | 1 | 0.0001 |
| 4 | Stimulant Laxative [EPC] | 1 | 0.0001 |
| 5 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 1 | 0.0001 |
| 6 | Calcium [EPC] | 8 | 0.0001 |
| 7 | Vitamin D3 Analog [EPC] | 1 | 0.0000 |
| 8 | Aminoglycoside Antibacterial [EPC] | 2 | 0.0000 |
| 9 | Parathyroid Hormone Analog [EPC] | 5 | 0.0000 |